Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1026
RPM International
RPM
$13.2B
| $29.9M | 0.01% |
303,251
+165,839
| +121% | +$17.6M |
2013 Q2
53 quarters
|
|
1027
Graco
GGG
$11.6B
| $29.9M | 0.01% |
389,240
+130,002
| +50% | +$10.2M |
2013 Q2
53 quarters
|
|
1028
PUT
Super Micro Computer
SMCI
$17.7B
| $29.9M | 0.01% |
728,000
+73,000
| +11% | +$2.48M |
2024 Q3
8 quarters
|
|
1029
Healthpeak Properties
DOC
$13.8B
| $29.8M | 0.01% |
1,493,282
+723,853
| +94% | +$15.4M |
2022 Q1
18 quarters
|
|
1030
T1 Energy
TE
$572M
| $29.8M | 0.01% |
7,725,589
+4,098,823
| +113% | +$21.1M |
2022 Q1
18 quarters
|
|
1031
Hubbell
HUBB
$23.1B
| $29.8M | 0.01% |
65,699
-4,816
| -7% | -$2.29M |
2015 Q4
43 quarters
|
|
1032
Cameco
CCJ
$30.8B
| $29.8M | 0.01% |
343,694
+51,778
| +18% | +$4.88M |
2013 Q2
53 quarters
|
|
1033
CALL
Praxis Precision Medicines
PRAX
$9.17B
| $29.6M | 0.01% |
+101,600
| New | +$33.6M |
2026 Q3
0 quarters
|
|
1034
TeraWulf
WULF
$6.33B
| $29.5M | 0.01% |
1,994,412
-157,102
| -7% | -$2.75M |
2023 Q4
11 quarters
|
|
1035
MasTec
MTZ
$14.7B
| $29.2M | 0.01% |
136,764
+28,690
| +27% | +$8.06M |
2016 Q1
42 quarters
|
|
1036
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$46B
| $29.2M | 0.01% |
57,321
-38,571
| -40% | -$20.3M |
2013 Q2
53 quarters
|
|
1037
WESCO International
WCC
$15.7B
| $29.1M | 0.01% |
81,012
+64,746
| +398% | +$22.3M |
2013 Q2
53 quarters
|
|
1038
FNB Corp
FNB
$6.38B
| $29M | 0.01% |
1,686,915
+1,088,715
| +182% | +$20.3M |
2013 Q2
53 quarters
|
|
1039
Definium Therapeutics
DFTX
$4.39B
| $29M | 0.01% |
761,867
+711,571
| +1,415% | +$30M |
2022 Q1
18 quarters
|
|
1040
SoFi Technologies
SOFI
$20B
| $29M | 0.01% |
1,844,275
-28,646
| -2% | -$504K |
2022 Q1
18 quarters
|
|
1041
Kinetik
KNTK
$4.42B
| $29M | 0.01% |
577,119
-401,144
| -41% | -$20.8M |
2022 Q1
18 quarters
|
|
1042
iShares Gold Trust
IAU
$57.5B
| $29M | 0.01% |
370,947
-509,920
| -58% | -$40.9M |
2022 Q1
18 quarters
|
|
1043
PUT
Johnson & Johnson
JNJ
$688B
| $29M | 0.01% |
109,400
+17,300
| +19% | +$4.56M |
2026 Q2
1 quarter
|
|
1044
CALL
McDonald's
MCD
$192B
| $28.9M | 0.01% |
125,000
-20,000
| -14% | -$5.26M |
2023 Q4
11 quarters
|
|
1045
iRhythm Holdings
IRTC
$3.05B
| $28.8M | 0.01% |
253,690
+61,892
| +32% | +$7.32M |
2022 Q1
18 quarters
|
|
1046
PUT
KLA
KLAC
$198B
| $28.6M | 0.01% |
146,900
+95,800
| +187% | +$18.8M |
2026 Q1
2 quarters
|
|
1047
Royal Gold
RGLD
$21.7B
| $28.6M | 0.01% |
121,299
+87,079
| +254% | +$20M |
2013 Q2
53 quarters
|
|
1048
Fox Class B
FOX
$25.8B
| $28.6M | 0.01% |
508,331
-462,510
| -48% | -$25.7M |
2019 Q1
30 quarters
|
|
1049
Plains GP Holdings
PAGP
$5.22B
| $28.5M | 0.01% |
1,100,624
-7,082
| -0.6% | -$187K |
2013 Q4
51 quarters
|
|
1050
CALL
Boeing
BA
$136B
| $28.5M | 0.01% |
+153,100
| New | +$32.8M |
2026 Q3
0 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.